The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Ponatinib

Australian Public Assessment Report

AusPAR

AusPAR: Ponatinib [PDF, 1.17 MB]

AusPAR: Ponatinib [Word, 1.19 MB]

Attachment: Product Information: Ponatinib [PDF, 344.57 KB]

Attachment: Product Information: Ponatinib [Word, 152.63 KB]

Attachment: Extract from the Clinical Evaluation Report: Ponatinib [PDF, 8 MB]

Attachment: Extract from the Clinical Evaluation Report: Ponatinib [Word, 19.78 MB]

Device/Product Name

Iclusig

Active ingredients

Ponatinib

AusPAR Date

16 April 2015

Published

17 June 2015

Submission Number

PM-2013-02061-1-4

Submission Type

New chemical entity

Decision

Approved